Hannah Bower

2.2k total citations · 1 hit paper
42 papers, 1.3k citations indexed

About

Hannah Bower is a scholar working on Oncology, Rheumatology and Hematology. According to data from OpenAlex, Hannah Bower has authored 42 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 16 papers in Rheumatology and 11 papers in Hematology. Recurrent topics in Hannah Bower's work include Rheumatoid Arthritis Research and Therapies (12 papers), Health Systems, Economic Evaluations, Quality of Life (6 papers) and Chronic Lymphocytic Leukemia Research (5 papers). Hannah Bower is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (12 papers), Health Systems, Economic Evaluations, Quality of Life (6 papers) and Chronic Lymphocytic Leukemia Research (5 papers). Hannah Bower collaborates with scholars based in Sweden, United Kingdom and United States. Hannah Bower's co-authors include Paul C. Lambert, Therése Andersson, Paul W. Dickman, Magnus Björkholm, Martin Höglund, Johan Askling, Thomas Frisell, Bénédicte Delcoigne, Daniela Di Giuseppe and Elisabet Lindqvist and has published in prestigious journals such as Journal of Clinical Oncology, Blood and American Journal of Epidemiology.

In The Last Decade

Hannah Bower

40 papers receiving 1.3k citations

Hit Papers

Life Expectancy of Patients With Chronic Myeloid Leukemia... 2016 2026 2019 2022 2016 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Life Expectancy of Patients With Chronic Myeloid Leukemia Approaches the Life Expectancy of the General Population
    2016 556 citations Hannah Bower, Magnus Björkholm et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hannah Bower Sweden 16 656 478 462 295 119 42 1.3k
Hemant Malhotra India 17 430 0.7× 377 0.8× 200 0.4× 239 0.8× 83 0.7× 72 973
Gabriela Hobbs United States 19 578 0.9× 536 1.1× 287 0.6× 263 0.9× 40 0.3× 133 1.2k
Anders Själander Sweden 24 322 0.5× 235 0.5× 115 0.2× 452 1.5× 117 1.0× 81 1.9k
Jeanna Welborn United States 17 395 0.6× 343 0.7× 109 0.2× 263 0.9× 120 1.0× 35 1.3k
Bin Jiang China 21 1.2k 1.8× 330 0.7× 114 0.2× 365 1.2× 60 0.5× 94 1.7k
Grace S. Park United States 19 221 0.3× 145 0.3× 860 1.9× 119 0.4× 361 3.0× 31 1.4k
Weiwei Feng China 18 220 0.3× 208 0.4× 85 0.2× 240 0.8× 89 0.7× 38 1.3k
Prasanth Ganesan India 18 265 0.4× 183 0.4× 64 0.1× 352 1.2× 197 1.7× 144 1.1k
Tim Littlewood United Kingdom 23 1.3k 1.9× 582 1.2× 68 0.1× 345 1.2× 85 0.7× 62 1.8k
Finn Wesenberg Norway 28 738 1.1× 181 0.4× 128 0.3× 219 0.7× 113 0.9× 87 2.2k

Countries citing papers authored by Hannah Bower

Since Specialization
Citations

This map shows the geographic impact of Hannah Bower's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hannah Bower with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hannah Bower more than expected).

Fields of papers citing papers by Hannah Bower

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hannah Bower. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hannah Bower. The network helps show where Hannah Bower may publish in the future.

Co-authorship network of co-authors of Hannah Bower

This figure shows the co-authorship network connecting the top 25 collaborators of Hannah Bower. A scholar is included among the top collaborators of Hannah Bower based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hannah Bower. Hannah Bower is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Bower, Hannah, Thomas Frisell, Daniela Di Giuseppe, et al.. (2023). Are JAKis more effective among elderly patients with RA, smokers and those with higher cardiovascular risk? A comparative effectiveness study of b/tsDMARDs in Sweden. RMD Open. 9(4). e003648–e003648. 1 indexed citations
3.
Frisell, Thomas, Hannah Bower, Eva Baecklund, et al.. (2023). Safety of biological and targeted synthetic disease-modifying antirheumatic drugs for rheumatoid arthritis as used in clinical practice: results from the ARTIS programme. Annals of the Rheumatic Diseases. 82(5). 601–610. 52 indexed citations
4.
Bower, Hannah, Thomas Frisell, Daniela Di Giuseppe, Bénédicte Delcoigne, & Johan Askling. (2023). Comparative cardiovascular safety with janus kinase inhibitors and biological disease-modifying antirheumatic drugs as used in clinical practice: an observational cohort study from Sweden in patients with rheumatoid arthritis. RMD Open. 9(4). e003630–e003630. 11 indexed citations
5.
Frisell, Thomas, Hannah Bower, Eva Baecklund, et al.. (2022). POS0637 SAFETY OF b/tsDMARDs FOR RA AS USED IN CLINICAL PRACTICE - RESULTS FROM THE LAST DECADE OF THE ARTIS PROGRAM. Annals of the Rheumatic Diseases. 81. 587–588. 2 indexed citations
6.
Bower, Hannah, Therése Andersson, Michael J. Crowther, & Paul C. Lambert. (2022). Flexible parametric survival analysis with multiple timescales: Estimation and implementation using stmt. The Stata Journal Promoting communications on statistics and Stata. 22(3). 679–701. 1 indexed citations
7.
Bower, Hannah, et al.. (2022). Venous thromboembolism with JAK inhibitors and other immune-modulatory drugs: a Swedish comparative safety study among patients with rheumatoid arthritis. Annals of the Rheumatic Diseases. 82(2). 189–197. 62 indexed citations
8.
Bower, Hannah, Paul W. Dickman, Anna Ravn Landtblom, et al.. (2022). Modelling multiple time-scales with flexible parametric survival models. BMC Medical Research Methodology. 22(1). 290–290. 2 indexed citations
9.
Bower, Hannah, Thomas Frisell, Daniela Di Giuseppe, et al.. (2021). POS1169 IMPACT OF THE COVID-19 PANDEMIC ON MORBIDITY AND MORTALITY AMONG SWEDISH PATIENTS WITH INFLAMMATORY JOINT DISEASES VERSUS THE GENERAL POPULATION. Annals of the Rheumatic Diseases. 80. 864–865. 1 indexed citations
10.
Giuseppe, Daniela Di, Hannah Bower, Bénédicte Delcoigne, et al.. (2021). POS0601 DIFFERENCES IN DRUG SURVIVAL BETWEEN ORIGINATOR AND BIOSIMILAR PRODUCTS AMONG FIRST USERS OF EACH MOLECULE. Annals of the Rheumatic Diseases. 80. 535–535. 1 indexed citations
11.
Bai, Ge, Agnieszka Szwajda, Yunzhang Wang, et al.. (2021). Frailty trajectories in three longitudinal studies of aging: Is the level or the rate of change more predictive of mortality?. Age and Ageing. 50(6). 2174–2182. 25 indexed citations
12.
Osvald, Emma Caffrey, Hannah Bower, Cecilia Lundholm, et al.. (2020). Asthma and all-cause mortality in children and young adults: a population-based study. Thorax. 75(12). 1040–1046. 25 indexed citations
13.
Plym, Anna, Anna L.V. Johansson, Hannah Bower, et al.. (2020). Impact of chemotherapy, radiotherapy, and endocrine therapy on sick leave in women with early-stage breast cancer during a 5-year period: a population-based cohort study. Breast Cancer Research and Treatment. 182(3). 699–707. 10 indexed citations
14.
Bower, Hannah, et al.. (2020). Risk of venous thromboembolism in rheumatoid arthritis, and its association with disease activity: a nationwide cohort study from Sweden. Annals of the Rheumatic Diseases. 80(2). 169–175. 74 indexed citations
15.
Plym, Anna, Hannah Bower, Irma Fredriksson, et al.. (2018). Loss in working years after a breast cancer diagnosis. British Journal of Cancer. 118(5). 738–743. 11 indexed citations
16.
Landtblom, Anna Ravn, Hannah Bower, Therése Andersson, et al.. (2018). Second malignancies in patients with myeloproliferative neoplasms: a population-based cohort study of 9379 patients. Leukemia. 32(10). 2203–2210. 52 indexed citations
17.
Bower, Hannah, et al.. (2017). Estimating the impact of a cancer diagnosis on life expectancy by socio-economic group for a range of cancer types in England. British Journal of Cancer. 117(9). 1419–1426. 39 indexed citations
18.
Creignou, Maria, Hannah Bower, Therése Andersson, et al.. (2016). Risk of Bleeding in 9,429 Patients with Philadelphia-Negative Myeloproliferative Neoplasms: a Population-Based Study from Sweden. Blood. 128(22). 946–946.
19.
Marlow, Neil, Hannah Bower, David R. Jones, et al.. (2016). The ORACLE Children Study: educational outcomes at 11 years of age following antenatal prescription of erythromycin or co-amoxiclav. Archives of Disease in Childhood Fetal & Neonatal. 102(2). F131–F135. 11 indexed citations
20.
Bower, Hannah, Therése Andersson, Magnus Björkholm, et al.. (2016). Continued improvement in survival of acute myeloid leukemia patients: an application of the loss in expectation of life. Blood Cancer Journal. 6(2). e390–e390. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hemant Malhotra Breakdown of academic impact, for papers by Gabriela Hobbs Breakdown of academic impact, for papers by Anders Själander Breakdown of academic impact, for papers by Jeanna Welborn Breakdown of academic impact, for papers by Bin Jiang Breakdown of academic impact, for papers by Grace S. Park Breakdown of academic impact, for papers by Weiwei Feng Breakdown of academic impact, for papers by Prasanth Ganesan Breakdown of academic impact, for papers by Tim Littlewood Breakdown of academic impact, for papers by Finn Wesenberg
Rankless by CCL
2026